CBD Science works with non-profit collectives, licensed dispensaries, patient cooperatives, and individuals throughout California to develop and produce CBMEs that are safe and effective. Extraction and blending processes follow SafeCannabis™ protocols. These practices insure that all CBD Science botanical drug substances are consistent in quality from batch to batch using the best organic botanical ingredients for our exclusive formulas. Our formulated tinctures are available through Alta California Botanicals and sold at licensed dispensaries throughout California.
Learn more at www.AltaCaliforniaBotanicals.com
CBD Science formulated tinctures are certified as SafeCannabis™ by Steep Hill-Halent Laboratories in Oakland, California. Quality control measures includes, third inspection, potency analysis, microbiological, and pesticide screening. Our products contain no harmful chemicals sometimes sometime associated with medical cannabis. These CBMEs are made from legally cultivated selected strains of organic cannabis. All of our formulations are tested and verified by Steep Hill-Halent Laboratories . Taken together, these practices along with Safe Cannabis™ certification makes our formulations the finest CBMEs available today.
The effectiveness of CBMEs are determined by quality ingredients and how they are blended together. CBD-Cannabidiol blended proportionally with THC-Tetrahydrocannabional are the primary active ingredients with trace amounts of other cannabinoids including CBG, CBL, CBC, and THCA. Each formula has been developed for a specific disease profile that cannabis has been shown effective in treating. Dosage differs with body weight and desired effects. A detailed guide to dosages using CBMSs is available on the Internet at: Cannabis Dosage Guide dot com, http://www.MedicalMarijuanaDosageGuide.com.
The human body makes it's own cannabinoids. These are known as endo cannabinoids and constitutes the human endo cannabinoid system. The National Institute of Health NIH recognizes the need for research and development of drugs and treatment protocols. Cannabinoid blends are known to be effective for systemic health issues including, irritable bowel syndrome, ulcerative colitis, and Crohn's Disease. The chart below address many of the known courses of treatment where cannabiniols when taken therapeutically with successful results.
Professor Raphael Mechoulam of Medicinal Chemistry and Natural Products at the Hebrew University describes cannabinoids as anti-inflammatory for arthritis, as neuroprotectant for brain injury, and as a possible treatment for PTSD.
SC Laboratories discribes Cannabinoid profiles including THC, THCA, THCV, CBD, CBG, CBN, CBC and terpenes.
"We are currently determining the molecular mechanism that may explain the synergistic increase in anticancer activity that is observed with the combination treatments".
-- Sean D. McAllister, PhD., Researcher at California Pacific Medical Center Research Institute